Novo Nordisk A/S announced a share repurchase program on August 7, 2024, intending to buy up to DKK 2.4 billion of B shares from August 7 to November 4, 2024, as part of a larger DKK 20 billion plan beginning February 6, 2024. Since then, they have repurchased 130,250 B shares for a total value of DKK 112.4 million with the total repurchased amount exceeding DKK 9.8 billion for 11.2 million B shares at an average price of DKK 878.79 each.